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Introduction
The recent successful applications of next-generation sequenc-
ing (NGS) technologies to identify disease-associated variants have
revolutionized biomedical and biological research, especially in
human disease studies [1,2]. Rapid advances in NGS technologies,
along with the dramatic decrease of cost, have propelled them to
become a major approach in research. As of September 2011,
more than 40 Mendelian diseases have been analyzed using whole
exome sequencing (WES) [3], and more than 10 complex diseases
have been studied using whole genome sequencing (WGS) and/or
WES, including, but not limited to, renal cancer [4], melanoma
[5], hepatocellular carcinoma [6], acute monocytic leukemia [7],
and head and neck squamous cell carcinoma [8]. While most of
the early NGS studies were conducted by large sequencing centers
or prominent research groups [2,9], the tremendous improvement
in technologies during the past two to three years has dramatically
reduced cost and hastened the speed of sequencing a genome
within a short period of time. Subsequently, NGS technologies are
now affordable and accessible to small or moderately sized
laboratories and are expected to quickly evolve as a routine
experimental technique in a similar fashion as the now common
use of microarray.
NGS generates massive amounts of data for genetic variant
detection. Thus, currently, a major bottleneck of NGS applications
is downstream bioinformatics analysis. This problem is especially
challenging for bench scientists. To meet this strong demand,
many investigators have been redirected to this new field and are
in the early stages of acquiring this technological knowledge,
especially pertaining to data analysis. Meanwhile, a great number
of computational tools dedicated to almost all aspects of NGS data
analyses have been developed during the past few years. However,
these tools are complicated and have project-specific features.
Firsthand experience in using these tools is important, especially
because investigators need to be able to readily identify true
variants for validation from the typically millions of variants called
by NGS computational tools. In this paper, we discuss four major
parameters that affect variant calling and the validation process,
aiming to provide some general guidelines to the NGS commu-
nity, especially for those new to NGS applications.
Among the various types of mutations that cause diseases, single
nucleotide variants (SNVs) and small insertions and deletions
(indels) are the most abundant. The detection of these variants is
critical in both WGS and WES studies. In the NGS data analysis
pipeline, SNV/indel calling is performed after mapping reads to a
reference genome, typically generating an initial set of SNVs/
indels. Based on several recently sequenced individual genomes
[10,11,12], a pattern has been recognized that, in general,
approximately 3–4 million SNVs are expected to be found in a
human genome by WGS when compared to the reference genome
[13], and ,20,000 SNVs are to be found in a human exome by
WES [14]. Some of these SNVs might, however, be false positives.
An open question is how to identify a set of SNVs with high
enough quality for follow up validation or further analysis. In an
early study by Ley et al. [15], the authors generated an initial
calling list of SNVs (,3.8 million SNVs) using the software Maq
[16] and then selected a subset of mutations from the list for
experimental validation. After they used their experimental data as
a training dataset for the Decision Tree C4.5 algorithm, the
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read counts, base quality and SNP quality scores), which were then
used to predict a small yet well supported set of ,2.6 million SNVs
with high accuracy [15]. In another study, Wei et al. [5] called
SNVs using the software bam2mpg [17] and developed a ratio
score to evaluate the quality of the initially called genotypes. Based
on their experimental data, the authors estimated a threshold of
this ratio score and used it to filter their initial list of SNVs.
These two studies, as well as several large-scale sequencing
projects [9,14], have shown that post-filtering of SNVs is essential
to identify variants that are more likely to be true while effectively
filtering false positives. Although not formulated, a few consistent
filtering rules have been recognized by the community, including
base quality, mapping quality, and coverage of supporting reads.
Additionally, there are several other factors that may affect the
accuracy of SNV/indel calling, such as sequence complexity and
the fitness of the algorithms used in a specific case. In this study,
we discuss four parameters that affect SNV and small indel calling,
which are critical in NGS applications. These parameters are (1)
variant quality and coverage, (2) refinement and improvement of
initial mapping, (3) allele/strand balance, and (4) examination of
spurious genes. Although some of them have been discussed in
previous studies in various forms [14,18,19], here, we systemat-
ically examined and demonstrated these rules using our own
experimental data, so that they may be generally applied to
different NGS data analyses.
Results and Discussion
Analysis Pipeline for SNV/Indel Detection
A straightforward, yet concise, pipeline to detect SNVs and
indels includes (1) sequencing, (2) pre-processing (e.g., quality
Figure 1. Pipelines for calling SNVs and indels. SNVs and indels are called by three options based on SAMtools (pileup or mpileup) and GATK
recalibration. Accordingly, three tiers of SNVs and indels are used for comparison. SNVs: single nucleotide variants. Indels: insertions and deletions.
doi:10.1371/journal.pone.0038470.g001
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reference genome using tools like the Burrows-Wheeler Alignment
tool (BWA) [20], Bowtie [21], or others, (4) post-processing of the
alignment results (e.g., marking duplicates, sorting, and indexing),
(5) calling SNVs/indels using tools such as SAMtools [19,22] and/
or the Unified Genotyper implemented in the Genome Analysis
Toolkit (GATK) [14], and (6) filtering (Figure 1). Advantages of
this workflow include that it is straightforward, uses robust
technologies (applicable to both WGS and WES), is fast to
execute especially for WGS data, and leads to an acceptable false
positive rate. In our implementation, we applied BWA (version
0.5.9) to map reads using all default parameters. The Picard tool
(version 1.52) was used to mark duplicates, and the SAMtools:m-
pileup function (version 0.1.13) was used to call SNVs/indels. In the
filtering step, we used ‘‘perl vcfutils.pl varFilter’’ with a ‘‘-d 3 -D
10000’’ option and other parameters by default and denoted the
results using this pipeline as the tier one variant set (see the
Materials and Methods section for details). We did not apply any
further filtering rules to the tier one variants, as our intention was
to search for parameters and rules that are effective for improving
the validation rate. For this purpose, we required an unbiased set
of variants for validation.
Alternatively, the GATK program can be incorporated before
variant calling. While GATK has a comprehensive list of functions
for almost all the NGS analyses, here, we focused on an
enhancement of our pipeline using GATK (Figure 1). Specifically,
we proposed the incorporation of GATK in the step after read
mapping and before SNV/indel calling by SAMtools:mpileup.
Among all the complicated tools implemented in GATK, we
found that two functions, the recalibration of mapping scores and
local realignment around indels, were particularly useful to
improve initial mapping results before SNV calling. After the
integration of these two steps, a new set of mapping results in
BAM/SAM format [22] were generated and analyzed using the
SAMtools:mpileup function for calling SNVs/indels, followed by
varFilter for initial filtering. We denoted the results as the tier two
variant set.
Of note, the function to call SNVs and indels in SAMtools
previously was pileup, which became obsolete since version 0.1.10
and was replaced by mpileup. Thus, most studies published in early
2011 or before used SAMtools:pileup. To compare performance
between these programs, we also implemented SAMtools:pileup
(version 0.1.13, pileup was still available in this version); results were
denoted as the tier three variant set.
Validation Dataset
We used real data generated from NGS of 18 tumor-normal
pairs using an Illumina HiSeq 2000 (Chen, Pao, Zhao and Ji,
unpublished data). Starting with the tier one variant set, we
selected a total of 181 mutations based on potential functional
importance, including both SNVs and indels called in the 18
cancer samples. The tier one set was generated based on the most
straightforward analysis pipeline, i.e., no post-improvement on the
alignment results or any filter rules on the initial results; thus, it
included almost all putative variants directly obtained from the
pipeline output. The false positive rate was expected to be high.
Among these 181 mutations, 159 were SNVs and 22 were indels
(Table 1). Primers were designed for each of these variant sites,
and traditional Sanger sequencing was used to sequence the
corresponding PCR products. Sixty-five of the SNVs were
validated as true variants, with a validation rate of 40.88%.
Similarly, 12 indels were validated, and the validation rate was
54.54%. Overall, the validation rate was low for SNVs/indels
detected without applying filtering.
To perform a systematic evaluation of the variants by three
tiers, we used the following indicators to distinguish different cases
of prediction and validation data.
N True Positive (TP): variants predicted and validated.
N False Positive (FP): variants predicted but failed in validation.
N False Negative (FN): variants not predicted but validated.
N True Negative (TN): variants not predicted and not validated.
Three parameters were introduced in our evaluation:
recall~
TP
TPzFN
, accuracy~
TP
TPzFP
, and an F score,
F~2|
accuracy|recall
accuracyzrecall
. Due to the limitation of the dataset,
we could not obtain an accurate computation for the area under
the receiver curve (AUC), a widely used term in data mining.
Rather, we incorporated the F score to assist with the selection of
parameters and create a balance between accuracy and recall.
Based on our evaluation, we summarized the following four points
that are critical for improving variant call.
Table 1. Comparison of validation of 159 SNVs and 22 indels by different parameter setting in variant calling.
Dataset Condition TP FP TN FN Validate rate Recall Accuracy
SNVs (159)
Tier One Initial calling 65 2 94 2 65/159=40.88%
Tier One QUAL$28, DP$5 50 9 85 15 50/65=76.92% 50/59=84.75%
Tier Two No filtering 65 80 14 0 65/65=100% 65/145=44.83%
Tier Two QUAL$23, DP$5
or QUAL$25, DP$3
59 10 70 6 59/65=90.77% 59/69=85.51%
Indels (22)
Tier One Initial calling 12 2 10 2 12/22=54.54%
Tier One QUAL$17, DP$3 12 1 9 0 12/12=100% 12/13=92.31%
Tier Two No filtering 9 10 0 3 9/12=75% 9/19=47.37%
Tier Two QUAL$21, DP$3 9 0 10 3 9/12=75% 9/9=100%
QUAL: quality score for SNVs and indels. DP: read depth. Definition of Tiers One and Two is provided in text and Figure 1. TP: true positive; FP: false positive; FN: false
negative; TN: true negative;recall~
TP
TPzFN
; accuracy~
TP
TPzFP
.
doi:10.1371/journal.pone.0038470.t001
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In early applications using SAMtools to call SNVs/indels, cutoff
values of 20 for SNV quality (hereafter denoted as QUAL) and 50
for indels were suggested [23]. In the recent versions of SAMtools,
mpileup has replaced pileup with a newly introduced concept of Base
Alignment Quality (BAQ) [19]. We were unable to find an explicit
recommendation for the cutoff values that are appropriate for
filtering putative SNVs/indels. To find the appropriate cutoff
values for mpileup, specifically for SNVs, we systematically
compared the QUAL values for the variants called by SAM-
tools:mpileup (tier one set) and SAMtools:pileup (tier three set) for
each of the 18 cancer samples. The Pearson correlation
coefficients were very high and in a small range (0.9872 to
0.9946) among the 18 samples, although SAMtools:pileup QUAL
scores were slightly higher than SAMtools:mpileup scores in .80%
cases. Results of one sample are provided in Figure S1. This
comparison indicates that the QUAL scores of variants called by
mpileup and pileup are quite similar. Accordingly, we suggest a cutoff
QUAL value ,20 can be generally applied to variants called by
SAMtools:mpileup.
To further explore which cutoff values are most appropriate, we
compared the performance of variant calling through our
validation dataset. Specifically, initial variants were separated into
different groups through possible combination values of QUAL
and read depth (DP). We limited QUAL values in the range
between 15 and 35 with a step-wise increase of 1 and DP in the
Figure 2. Distribution of accuracy versus recall by different combinations of quality score (QUAL) and read depth (DP) values in two
sets (tiers 1 and 2) of SNVs and indels. (a) Tier One SNVs. (b) Tier Two SNVs. (c) Tier One Indels. (d) Tier Two Indels. For each variant set (panel),
each node represents a combination of cutoff values for QUAL and DP. Specifically, the QUAL cutoff was selected by an integer value in the range of
15 to 35 with an increment of 1 each time, and the DP cutoff by an integer value in the range of 3 to 15 with an increment of 1 each time. Then, we
evaluated the accuracy, recall, and F score (see text) for each cutoff combination. Note that many nodes are overlapped on the panel and shown by
jitter (i.e., points at the same locations are slightly shifted for visibility). The combination of values that could generate the highest F score was
selected (shown in red points).
doi:10.1371/journal.pone.0038470.g002
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recall, accuracy, and F score for each of the possible combinations
of QUAL and DP were computed and compared, with the goal of
finding the combination of QUAL and DP scores that could
generate the highest F score. For tier one variants, we found that
with QUAL $28 and DP$5, the highest F score (0.8065) could be
achieved and a total of 50 of the 65 validated SNVs could be
recruited (recall =76.92%), with an accuracy rate of 84.75%
(Figures 2a and 3a and Table 1). For tier one indels, using QUAL
$17 and DP$3, all 12 validated mutations could be recalled
(100%), with an accuracy rate of 92.31% (Table 1, Figures 2c and
3c). Although the F score may not be the most appropriate for
identifying QUAL and DP cutoff values, its notion of making a
trade-off between accuracy and recall is reasonable. We expect to
further improve this evaluation approach for identifying cutoff
values. For example, another combination for tier one indels,
QUAL $21 and DP$3, could generate a higher accuracy (100%)
with a slight decrease in the recall rate: only 11 indels could be
recalled (11/12=91.67%) (Figure 2c). Therefore, if high accuracy
is a high priority and resources allow only a limited number of
variants to be validated, the options ‘‘QUAL $21 and DP$3’’ is
preferred. On the other hand, if the goal is to search for and
validate as many possible variants with abundant resources
available, ‘‘QUAL $17 and DP$3’’ could be adopted.
Point 2: Realignment and Recalibration Improve Variant
Calling
When using the validation data to compare variant calling in
the tier one and two sets, we had better performance measured by
both recall and accuracy, especially for SNVs. With QUAL $23
and DP$5, or QUAL $25 and DP$3, we could recruit 59 tier
two SNVs (recall =90.77%) with an accuracy of 85.51%
(Figures 2b and 3b). This result was compared to the highest
recall rate (76.92%) and accuracy rate (84.75%) using tier one
Figure 3. Distribution of read depth (DP) versus SNV quality score (QUAL) for the SNVs or indels selected for validation. (a) Tier One
SNVs (159 SNVs), (b) Tier Two SNVs (145 SNVs), (c) Tier One Indels (22 indels), and (d) Tier Two Indels (19 indels). Variants in blue denote successful
validation, and variants in red denote failure in validation. In each panel, the vertical dash line indicates the cutoff value for QUAL, and the horizontal
dash line indicates cutoff value for DP (see Point 2 in the main text and Table 1).
doi:10.1371/journal.pone.0038470.g003
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38470Figure 4. Allele and strand bias for SNVs. This figure shows read distribution of called variants to reference or alternative (i.e., non-reference)
alleles in forward or reverse strand. (a) Tier One SNVs passed validation. (b) Tier One SNVs failed in validation. (c) Tier Two SNVs passed validation. (d)
Tier Two SNVs failed in validation. Red: reference base forward; pink: reference base reverse; blue: alternative base forward; and cyan: alternative base
reverse. The arrows under the x-axis indicate the variants lacked supporting reads for one or more of the four allele/strand cases.
doi:10.1371/journal.pone.0038470.g004
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validated indels were recruited (Figures 2d and 3d), which is
slightly lower than the tier one data where all 12 validated indels
could be recruited and the accuracy was 100%.
For both tier one and tier two sets, the cutoff values we proposed
here might be variant set-specific and may vary according to
specific conditions; thus, there is no need to follow the exact
values. Rather, our values here demonstrate, based on our data
and experience, that a cutoff around 20–25 for SNV quality and
read depth $5, or higher, if data allows, would lead to a high
validation rate when using the pipeline for the tier two variant set.
Point 3: Allele and Strand Bias
Other factors that have been previously mentioned [14,24]
include a required supporting read number regarding the
reference or alternative alleles in the forward and reverse strands,
respectively. We systematically examined the allele and strand
distribution of the validation data in the tier one and two variant
sets (Figure 4). For each variant site, four numbers of ‘‘high-
quality’’ reads were obtained respectively for (1) reference allele
forward (RF), (2) reference allele reverse (RR), (3) alternate allele
forward (AF), and (4) alternative allele reverse (AR). Here, ‘‘high-
quality reads’’ indicate those that were literally used in SNV/indel
calling by SAMtools:mpileup function and were reported as the
‘‘DP4’’ item in the resultant files in VCF format [25]. As shown in
Figure 4, we indeed observed a strong difference between the
variants passing validation and those that failed in validation. To
describe this quantitatively, in each scenario, we counted the
number of variants with at least one supporting read for all four
allele/strand combinations and those with no supporting reads in
any of the four combinations (Figure 5a), and then constructed
262 contingency tables (Figure 5b and 5c). Fisher’s exact test
showed that there was a significant difference between the read
distribution and validation status (P =1.76610
25 for tier one
variant set and P =1.27610
24 for tier two variant set). However,
when we attempted to use this rule to perform prediction, i.e.,
requiring at least one supporting read for each of the 4 base/
strand combinations, we did not find that recall or accuracy
improved substantially. Thus, no filtering rules based on the
allele/strand balance were explicitly applied in our analysis. Even
so, this lack of improvement might occur in our data specifically.
Overall, we suggest that researchers check the allele/strand bias in
their own projects.
Point 4: Manual Check of Spurious Genes
Previous studies have noticed the phenomenon of spurious
genes (genes with spurious mutations found in many samples or
different projects) caused by similar regions in the genome [18].
These genes, e.g., CDC27, CTBP2, and OR4C3, have been
frequently predicted, in different projects, to have mutations, but
these findings were finally proved to be artifacts [1,26,27]. The
details of spurious genes in NGS data have yet to be explored. A
possible scenario is described below. Suppose there are two regions
A and B in the genome. Region A is included in the current
version of the reference genome, but region B is not due to the
incompleteness of our knowledge. Using currently available
mapping tools, the reads that are initially generated by region B
will hardly be confidently mapped to any region in the genome
and will be discarded. However, if the similarity between the two
regions is very high and the read is short, it would be possible that
the reads that are originally generated by region B will be assigned
to region A with mismatches, and these ‘‘mismatches’’ could
subsequently be reported as putative SNVs/indels in region A. Ju
et al. [28] proposed ‘‘super’’ genes to classify this type of gene,
which was found to have a high density of detected SNVs in their
genomic regions. We observed that CDC27 was frequently
predicted to have mutations in several of our in-house exome
sequencing projects with different phenotypes (data not shown). It
is important to distinguish such genes, especially when sequencing
a number of cancer samples, because in such conditions,
investigators would be particularly interested in searching for
genes with a high mutation frequency in multiple samples.
Without warning, it is likely that investigators will identify top
candidate genes with a high frequency of spurious mutations.
Should this occur, such artifacts could waste a lot of resources in
validation work, or even lead to false discovery reporting in the
literature.
To explore systematically the existence of spurious genes, we
carefully examined several known spurious genes/mutations (e.g.,
CDC27) and found that they tend to have two features: (1) high
coverage around the variation site, which could be partially
explained by incorrect assignment of reads (see above), and (2) low
quality of local alignment. Figure 6 shows an example of good
alignment that has most of the bases matched perfectly to the
reference genome except at the SNV site (Figure 6a), and an
example of bad alignment that has many mismatched bases within
each read (Figure 6b, the local alignment around two exons of
CDC27). Additionally, a long segment of the sequences around the
target regions is normally involved. Hence, the bad alignment will
exist across several bases rather than only the targeted site.
Therefore, we recommend describing the ‘‘local alignment
environment’’ of a variant locus rather than only considering the
alignment at the locus. In this work, we considered each exon as
an analysis unit.
For each exon, we proposed two parameters to quantitatively
measure these features in order to facilitate a manual check of
Figure 5. An illustration of Fisher’s exact test for allele and
strand balance. On the top panel (a), the table shows how we
summarized the counts for each mutation site (shown in each column
and denoted by M) in each of the four cases: reference forward,
reference reverse, alternative forward, and alternative reverse. A variant
is indicated by 1 if it does not have a supporting read in one or more
cases; otherwise, it is indicated by 0. The contingency tables for the Tier
One dataset and Tier Two dataset were constructed as shown in (b) and
(c), respectively.
doi:10.1371/journal.pone.0038470.g005
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of an exon, we derived a parameter RPE to denote the
normalized number of Reads Per Exon: RPE~
#reads|106
exon length|
P
e[fexonsg
#readse
. In this formula, the absolute
number of reads for an exon is normalized (1) by its length
(exon_length) so that different exons with different lengths are
comparable to each other, and (2) by the total number of reads
mapped to exon regions (
P
e[fexonsg
#readse) for each sample so that
the same exon in different samples can be compared. Secondly, we
define a parameter PHQR to compute the Proportion of High-
Quality Reads (HQRs) for each exon. In the alignment results by
BWA, each read is assigned a mapping quality (MAPQ), defined
as -106log10Pr(mapping position is wrong) and rounded to the nearest
integer [22]. The MAPQ values range between 0 and 60, with
higher values indicating high mapping quality (Figure 6c). We
used the MAPQ information to indicate if a read has high-quality
if its MAPQ was higher than or equal to 40, and the proportion of
such high-quality reads for each exon was then computed as PHQR.
The cutoff value of 40 was selected based on the overall
distribution of mapping quality (Figure 6c). Of note, a pre-filtering
step on MAPQ is expected to be executed on the initial alignment
file (BAM/SAM) before SNV/indel calling, e.g., the command
Figure 6. A visual examination of a spurious gene (CDC27). The top panels show visualization of read alignment in good (a) and bad (b)
conditions using the software IGV [29]. The top part of each figure shows the coverage. Each grey bar represents one read, with the color grey
indicating it is matched well with the reference and other colors indicating mismatches. Panel (c) shows the distribution of mapping quality (MAPQ)
of all the reads in a representative sample. MAPQ is defined as -106log10Pr(mapping position is wrong), rounded to the nearest integer. As shown on
the x-axis in (c), MAPQ ranges between 0 and 60 in this sample, with 60 indicating the best mapping. Y-axis in (c) is the number of reads in this
sample. Panel (d) shows the distribution of MAPQ of all the reads in a sample and the reads mapped to CDC27 exon regions. Y-axis in (d) is the
proportion of reads in each MAPQ range (x-axis).
doi:10.1371/journal.pone.0038470.g006
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multiple positions by the ‘‘-q’’ option [23]. However, the value
used in this step (-q) is typically not as high as 40, because this
setting could be too strict and, in turn, remove numerous reads. In
summary, in the alignment files used for SNV/indel calling, the
MAPQ values vary widely, and PHQR could be used to indicate the
overall alignment quality.
Figure 7 displays the distribution of PHQR versus RPE in our
samples. In the figure, each point represents an exon and grey
nodes indicate the cohort of all exons. We specifically examined
the distribution of the gene CDC27 (CCDS11509.1) and its 19
exons in all 36 samples. Here, we also included the matched
control samples because the spurious gene phenomenon is a
systematic artifact and is expected to occur in any samples
regardless of disease status. As shown in Figure 7, one exon of
CDC27 was observed to depart from the major distribution (red
points), and this phenomenon occurred in all the 36 samples. In
the plot panel (Figure 7), this exon is located in the right bottom
area where the coverage is high (x-axis), and the proportion of
high-quality reads is low (y-axis), which is consistent with the two
features we have expected (see above). We manually set this region
as RPE.1.5 and PHQR,0.4 and then collected all the exons that
were located in this area. After ranking these exons according to
their number of occurrence samples, we identified a total of 10
genes observed in more than 30 samples (83% of 36 samples)
(Table 2). Again, these cutoff values are arbitrary. Researchers
may apply a more stringent cutoff to require occurrence in .90%
of samples or refine the area in the plot by setting RPE and PHQR.
However, one may need to be cautious of the possibility false
positives regarding the exons we listed in Table 2. Manual
examination of local alignment should be performed before
experimental validation to save efforts and resource.
Figure 7. Detection of spurious genes. RPE: the number of Reads Per Exon after adjusting the length of the exon and the overall sequencing
depth per sample. PHQR: the Proportion of High-Quality Reads for each exon. Each point represents an exon. The grey points represent all the exons in
one sample. The red points indicate the distribution of the 13
th exon of the gene CDC27 in all 36 samples, and purple points indicate the distribution
of the 42
nd exon of the gene MLL3 in all 36 samples, both of which are representative spurious genes and failed to be validated by experiments. The
vertical dash line is set RPE =1.5 and the horizontal dash line is set PHQR =0.4.
doi:10.1371/journal.pone.0038470.g007
Table 2. Spurious genes having mutations detected in .30
samples.
CCDS ID Gene symbol Exon # samples
CCDS11509.1 CDC27 13
th 36
CCDS12749.1 CGB 3
rd 36
CCDS12752.1 CGB5 1
st 36
CCDS41378.1 NBPF11 19
th 36
CCDS43407.1 FAM153C 4
th 36
CCDS5931.1 MLL3 42
nd 36
CCDS34703.1 STAG3 33
rd 34
CCDS5590.1 POMZP3 1
st 34
CCDS10638.1 EIF3C 8
th 32
CCDS30836.1 NBPF14 22
nd 31
CCDS: Consensus coding sequence. Exon: the specific exon in which the
variants are detected.
doi:10.1371/journal.pone.0038470.t002
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38470The gene/exon lists, either by Ju et al. [28] or by our work, and
cutoff values for spurious genes may vary depending on different
runs and platforms. However, the main features of high coverage
and low proportion of high-quality reads are typical for these
genes. While the genes in Table 2 display the need for investigators
to take extra caution, we suggest they check for the local alignment
or draw similar figures in their specific NGS projects. Manual
examination of the local alignment environment could remove
most of these genes effectively. This examination is performed
after SNV/indel calling and before experimental validation.
In conclusion, we systematically examined the major factors
that could potentially improve validation rates in next-generation
sequencing data and summarized four parameters aiming to
provide general guidelines. These parameters are (1) both quality
and read depth are important factors in variant detection; (2)
realignment and recalibration help improving variant calling; (3)
there are allele and strand difference between the positions that
have been successfully validated and those that have failed in
validation; and (4) manual check could help filter spurious genes.
These points provide useful and timely guidelines in the selection
of software/pipelines for calling SNVs/indels and in the follow up
selection of variants for validation. A high validation rate not only
reduces the cost and labors in experimental validation of NGS
data, but also avoids reporting false discoveries in literature or
public databases. Although we identified these points primarily
based on exome data, they could also readily be applicable to
WGS data.
Materials and Methods
A total of 18 lung tumor:normal pairs were captured using the
Agilent SureSelect 38 M kit and sequenced on an Illumina HiSeq
2000 platform. On average, 48 Mb paired-end reads were
generated per sample with an average sequencing depth of 636
on targeted regions. This study was approved by the Institutional
Review Board of the Fudan University Shanghai Cancer Center,
Shanghai, China. All participants gave written informed consent.
Details of the sequencing strategy and description of the datasets
are provided elsewhere (manuscript in preparation).
The overall pipeline is shown in Figure 1. Briefly, all three
resultant variant sets were based on the same mapping results
initially generated using BWA [20] to map reads of each sample to
the human reference genome (hg18). Duplicate reads and reads
with a Phred-based quality score ,15 were removed from
subsequent analyses. Cleaned alignment result files in the BAM
format were then prepared for variant calling. The NGS data
analyses were conducted in a high performance computing cluster
comprising 3700 processor cores and having a theoretical peak
performance of 12 TeraFLOPS available at the Vanderbilt
Advance Computing Center for Research and Education
(ACCRE, http://www.accre.vanderbilt.edu/).
For the tier one variant set, we called SNVs/indels using the
SAMtools:mpileup function and filtered the resultant variations
using the varFilter function provided by the vcfutils.pl script in
SAMtools using ‘‘-d3 -D10000’’ option, i.e., requiring 3 or more
but no more than 10,000 read depth for each putative variant. For
the tier two variant set, we performed base quality score
recalibration and local realignment around known indels based
on the initial alignment results, followed by SNV/indel detection
in the same way we did for the tier one set using the
SAMtools:mpileup function and filtering. For the tier three variant
set, we called SNVs/indels using the initial alignment files as we
used for tier one set, but we used the SAMtools:pileup function.
A filtering step using ‘‘$3= =‘‘*’’&&$6.=50) ||
($3!=‘‘*’’&&$6.=20’’ was applied on the resultant file by
varFilter implemented in the samtools.pl script [23]. The detailed
functional commands are available upon request.
Supporting Information
Figure S1 Distribution of Pearson correlation coeffi-
cient of the QUAL values by SAMtools:pileup and
SAMtools:mpileup in one representative lung cancer
sample. Each node represents one putative SNV or indel called
by both functions. The red line is y=x.
(PDF)
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